Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 33 results.
User Information
Export Records
  1. 1.   Leveraging long-acting IL-15 agonists for intratumoral delivery and enhanced antimetastatic activity
  2. Hangasky, John A; Fernández, Rocío Del Valle; Stellas,Dimitris; Hails, Guillermo; Karaliota,Sevasti; Ashley, Gary W; Felber,Barbara; Pavlakis,George; Santi, Daniel V
  3. Frontiers in Immunology. 2024, Nov 4; 15: 1458145.
  1. 2.   High baseline frequencies of natural killer cells are associated with asymptomatic SARS-CoV-2 infection
  2. Graydon, Elizabeth K; Malloy, Allison M W; Machmach, Kawthar; Sun, Peifang; Paquin-Proulx, Dominic; Lizewski, Stephen; Lizewski, Rhonda; Weir, Dawn L; Goforth, Carl W; Anderson,Steve; Letizia, Andrew G; Mitre, Edward
  3. Current Research in Immunology. 2023, Jul 15; 4: 100064.
  1. 3.   Natural Killer Cells Regulate Acute SIV Replication, Dissemination, and Inflammation, but Do Not Impact Independent Transmission Events
  2. Woolley, Griffin; Mosher, Matthew; Kroll, Kyle; Jones, Rhianna; Hueber, Brady; Sugawara, Sho; Manickam, Cordelia; Terry, Karen; Varner, Valerie; Lifton, Michelle; Ram, Daniel; Fennessey,Christine; Keele,Brandon; Reeves, R Keith
  3. Journal of Virology. 2022, Dec 13; e0151922.
  1. 4.   Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients
  2. Ivison, Geoffrey T; Vendrame, Elena; Martínez-Colón, Giovanny J; Ranganath, Thanmayi; Vergara, Rosemary; Zhao, Nancy Q; Martin,Pat; Bendall, Sean C; Carrington,Mary; Cyktor, Joshua C; McMahon, Deborah K; Eron, Joseph; Jones, R Brad; Mellors, John W; Bosch, Ronald J; Gandhi, Rajesh T; Holmes, Susan; Blish, Catherine A
  3. Frontiers in Cellular and Infection Microbiology. 2022 12: 757846.
  1. 5.   Adaptive Admixture of HLA Class I Allotypes Enhanced Genetically Determined Strength of Natural Killer Cells in East Asians
  2. Deng, Zhihui; Zhen, Jianxin; Harrison, Genelle F.; Zhang, Guobin; Chen, Rui; Sun, Ge; Yu, Qiong; Nemat-Gorgani, Neda; Guethlein, Lisbeth A.; He, Liumei; Tang, Mingzhong; Gao, Xiaojiang; Cai, Siqi; Palmer, William H.; Shortt, Jonathan A.; Gignoux, Christopher R.; Carrington,Mary; Zou, Hongyan; Parham, Peter; Hong, Wenxu; Norman, Paul J.
  3. Molecular Biology and Evolution. 2021, May 19; 38(6): 2582-2596.
  1. 6.   Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome
  2. Childs, Richard W; Tian, Xin; Vo, Phuong; Purev, Enkhtsetseg; Kotecha, Ritesh R; Carlsten, Mattias; Clara, Joseph; Flegel, Willy A; Adams, Sharon D; Khuu, Hanh M; Stroncek, David F; Cook, Lisa; Worthy, Tat'yana; Geller, Nancy L; Wells, Brian; Wilder,Jennifer; Reger, Robert; Aue, Georg
  3. British Journal of Haematology. 2021, May 15; 193(5): 951-960.
  1. 7.   Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer
  2. Zeligs, Kristen P.; Morelli, Maria Pia; David, Justin M.; Neuman, Monica; Hernandez, Lidia; Hewitt, Stephen; Ozaki, Michelle; Osei-Tutu, Akosua; Anderson, David; Andresson,Thorkell; Das,Sudipto; Lack,Justin; Abdelmaksoud,Abdalla; Fantini, Massimo; Arlen, Philip M.; Tsang, Kwong Y.; Annunziata, Christina M.
  3. FRONTIERS IN ONCOLOGY. 2020, JUN 19; 10: 805.
  1. 8.   CD47 Expression in Natural Killer Cells Regulates Homeostasis and Modulates Immune Response to Lymphocytic Choriomeningitis Virus
  2. Nath, Pulak Ranjan; Gangaplara, Arunakumar; Pal-Nath, Dipasmita; Mandal, Ajeet; Maric, Dragan; Sipes, John M.; Cam, Maggie; Shevach, Ethan M.; Roberts, David D.
  3. FRONTIERS IN IMMUNOLOGY. 2018, Dec 20; 9
  1. 9.   HIV-1-Mediated Downmodulation of HLA-C Impacts Target Cell Recognition and Antiviral Activity of NK Cells
  2. Körner, Christian; Simoneau, Camille R; Schommers, Philipp; Granoff, Mitchell; Ziegler, Maja; Hölzemer, Angelique; Lunemann, Sebastian; Chukwukelu, Janet; Corleis, Björn; Naranbhai, Vivek; Kwon, Douglas S; Scully, Eileen P; Jost, Stephanie; Kirchhoff, Frank; Carrington, Mary; Altfeld, Marcus
  3. Cell Host & Microbe. 2017, Jul 12; 22(1): 111-+.
  1. 10.   Killer Immunoglobulin-Like Receptor Transcriptional Regulation: A Fascinating Dance of Multiple Promoters
  2. Cichocki, F.; Miller, J. S.; Anderson, S. K.
  3. Journal of Innate Immunity. 2011, Apr; 3(3): 242-248.
  1. 11.   Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela
  2. Conesa, A.; Fernandez-Mestre, M.; Padron, D.; Toro, F.; Silva, N.; Tassinari, P.; Blanca, I.; Martin, M. P.; Carrington, M.; Layrisse, Z.
  3. Tissue Antigens. 2010, Jun; 75(6): 724-729.
  1. 12.   New flow cytometric assays for monitoring cell-mediated cytotoxicity
  2. Zaritskaya, L.; Shurin, M. R.; Sayers, T. J.; Malyguine, A. M.
  3. Expert Review of Vaccines. 2010, Jun; 9(6): 601-616.
  1. 13.   In vivo expression of signaling proteins in reconstituted NK cells
  2. Orr, S. J.; Quigley, L.; McVicar, D. W.
  3. Journal of Immunological Methods. 2009 340(2): 158-163.
  1. 14.   Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome
  2. Belanger, S.; Tai, L. H.; Anderson, S. K.; Makrigiannis, A. P.
  3. Genes and Immunity. 2008 9(6): 509-521.
  1. 15.   KIR and disease: a model system or system of models?
  2. Khakoo, S. I.; Carrington, M.
  3. Immunological Reviews. 2006, Dec; 214: 186-201.
  1. 16.   Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough!
  2. Pascal, V.; Stulberg, M. J.; Anderson, S. K.
  3. Immunological Reviews. 2006, Dec; 214: 9-21.
  1. 18.   Antiviral synergism
  2. Carrington, M.
  3. Nature Genetics. 2005, JUN; 37(6): 565-566.
  1. 19.   NFkB affects Natural Killer cell development by regulating the Ly49 repertoire
  2. Pascal, V.; Abshari, M.; Anderson, S. K.
  3. Faseb Journal. 2005, MAR 4; 19(4, Part 1 Suppl. S): A918-A918.
  1. 20.   Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes
  2. Makrigiannis, A. P.; Patel, D.; Goulet, M. L.; Dewar, K.; Anderson, S. K.
  3. Genes and Immunity. 2005, MAR; 6(2): 71-83.
  1. 21.   Hydrodynamics-based gene delivery of a novel interleukin-15 plasmid augments natural killer cell activities and suppresses lung metastasis
  2. Yazawa, H.; Ortaldo, J. R.; Back, T. C.; Subleski, J. J.; Seki, N.; Reynolds, D. M.; Winkler-Pickett, R. T.; Wiltrout, R. H.; Watanabe, M.
  3. Journal of Immunotherapy. 2005, NOV-DEC; 28(6): 627-627.
  1. 22.   Fixation and cryopreservation of whole blood and isolated mononuclear cells: Influence of different procedures on lymphocyte subset analysis by flow cytometry
  2. Pinto, L. A.; Trivett, M. T.; Wallace, D.; Higgins, J.; Baseler, M.; Terabe, M.; Belyakov, I. M.; Berzofsky, J. A.; Hildesheim, A.
  3. Cytometry Part B-Clinical Cytometry. 2005, JAN; 63B(1): 47-55.
  1. 23.   Peroxisome proliferator-activated receptor-gamma and its ligands attenuate biologic functions of human natural killer cells
  2. Zhang, X.; Rodriguez-Galan, M. C.; Subleski, J. J.; Ortaldo, J. R.; Hodge, D. L.; Wang, J. M.; Shimozato, O.; Reynolds, D. A.; Young, H. A.
  3. Blood. 2004, NOV 15; 104(10): 3276-3284.
  1. 24.   Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success
  2. Hiby, S. E.; Walker, J. J.; O'Shaughnessy, K. M.; Redman, C. W. G.; Carrington, M.; Trowsdale, J.; Moffett, A.
  3. Journal of Experimental Medicine. 2004, OCT 18; 200(8): 957-965.
  1. 25.   Proteomic investigation of natural killer cell microsomes using gas-phase fractionation by mass spectrometry
  2. Blonder, J.; Rodriguez-Galan, M. C.; Lucas, D. A.; Young, H. A.; Issaq, H. J.; Veenstra, T. D.; Conrads, T. P.
  3. Biochimica Et Biophysica Acta-Proteins and Proteomics. 2004 1698(1): 87-95.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel